Stock REMI REMEDENT, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Remedent, Inc.

Equities

REMI

US75954T1043

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets
Other stock markets
 11:11:52 12/04/2024 pm IST 		5-day change 1st Jan Change
0.055 USD -15.84% Intraday chart for Remedent, Inc. -.--% -43.30%
2023 Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
2022 Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2022 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 3.868 3.424 3.146 3.105 2.995 3.066
Enterprise Value (EV) 2 3.827 3.357 3.119 3.104 2.992 3.038
P/E ratio -73.5 x 1.67 x -3.8 x - - -
Yield - - - - - -
Capitalization / Revenue 1.43 x 2.13 x 2.96 x 10.7 x 7.45 x 66.5 x
EV / Revenue 1.42 x 2.09 x 2.93 x 10.7 x 7.44 x 65.9 x
EV / EBITDA -19.1 x -5.42 x -7.64 x 83.3 x 33.2 x -11.9 x
EV / FCF -231 x 3.39 x 20.4 x - - -
FCF Yield -0.43% 29.5% 4.91% - - -
Price to Book 1.2 x 0.63 x 0.69 x - - -
Nbr of stocks (in thousands) 19,273 19,273 19,273 19,273 19,273 19,273
Reference price 3 0.2007 0.1776 0.1633 0.1611 0.1554 0.1591
Announcement Date 13/07/18 28/06/19 30/06/20 13/08/21 20/09/22 22/11/23
1EUR in Million2USD in Million3EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 2.7 1.604 1.064 0.2889 0.4019 0.0461
EBITDA 1 -0.2005 -0.6196 -0.4084 0.0373 0.0902 -0.2553
EBIT 1 -0.3008 -0.7173 -0.4796 0.005216 0.0681 -0.2767
Operating Margin -11.14% -44.73% -45.06% 1.81% 16.95% -599.97%
Earnings before Tax (EBT) 1 -0.0419 2.12 -0.8519 0.009254 0.1325 -0.3037
Net income 1 -0.0546 2.129 -0.8582 0.008955 0.1319 -0.3041
Net margin -2.02% 132.74% -80.63% 3.1% 32.81% -659.55%
EPS 2 -0.002730 0.1065 -0.0429 - - -
Free Cash Flow 1 -0.0165 0.9899 0.1532 - - -
FCF margin -0.61% 61.73% 14.39% - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - 46.5% - - - -
Dividend per Share - - - - - -
Announcement Date 13/07/18 28/06/19 30/06/20 13/08/21 20/09/22 22/11/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 0.04 0.07 0.03 0 0 0.03
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -0.02 0.99 0.15 - - -
ROE (net income / shareholders' equity) -1.34% 48.3% -16.9% 0.29% 4.2% -9.96%
ROA (Net income/ Total Assets) -3.7% -6.72% -3.89% 0.08% 0.96% -3.8%
Assets 1 1.476 -31.66 22.05 11.72 13.76 7.993
Book Value Per Share 2 0.1700 0.2800 0.2400 - - -
Cash Flow per Share 2 0 0 0.0100 - - -
Capex 1 0 - - - - -
Capex / Sales 0.17% - - - - -
Announcement Date 13/07/18 28/06/19 30/06/20 13/08/21 20/09/22 22/11/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
REMEDENT, INC. Stock Remedent, Inc.
-43.30% 1.06M
ABBOTT LABORATORIES Stock Abbott Laboratories
-5.51% 182B
MEDTRONIC PLC Stock Medtronic plc
+2.33% 111B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-3.62% 68.48B
DEXCOM, INC. Stock DexCom, Inc.
+1.52% 49.69B
CENCORA, INC. Stock Cencora, Inc.
+8.06% 44.46B
HOYA CORPORATION Stock Hoya Corporation
+6.35% 40.67B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+23.35% 31.22B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+0.67% 26.09B
TERUMO CORPORATION Stock Terumo Corporation
+18.43% 25.32B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. REMI Stock
  4. Financials Remedent, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW